Effects of the Consumption of Broccoli Sprouts in Overweight Subjects
SPROUTvsFAT
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
Nowadays there is an increasing demand by consumers on healthy food products prepared in convenient forms, simple to use and not containing additives. In this sense, broccoli sprouts (Brassica oleraceae var. italica) represent an interesting choice as they are rich in glucosinolates, nitrogen-sulfur compounds, that are believed to counteract the negative effects of diverse pathologies. Human studies have been focused on the antitumoral properties of these vegetables, however there is less evidence on the anti-inflammatory properties of cruciferous vegetables in humans. As obesity is linked to an inflammatory component, the aim of the study is to evaluate the anti-inflammatory action of broccoli sprouts in overweight adult subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Feb 2015
Typical duration for not_applicable obesity
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedFirst Submitted
Initial submission to the registry
December 28, 2017
CompletedFirst Posted
Study publicly available on registry
January 4, 2018
CompletedJanuary 4, 2018
December 1, 2017
1.4 years
December 28, 2017
December 28, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in IL-6 levels
Plasma levels of IL-6 measured at days 0, 70, 90 and 160 days of intervention
Changes observed from baseline at day 0 compared to 70, 90, 160 days
Change in C-reactive protein
Plasma levels of C-reactive protein measured at days 0, 70, 90 and 160 days of intervention
Changes observed from baseline at day 0 compared to 70, 90, 160 days
Secondary Outcomes (1)
Bioavailability of glucosinolates from broccoli sprouts
Changes observed from baseline at day 0 compared to 70, 90, 160 days
Study Arms (1)
Broccoli sprout and follow up
EXPERIMENTALDaily consumption of 30 g of raw, fresh, broccoli sprouts, not cooked, during 10 weeks (70 days), followed by other 90 days of no ingestion of broccoli sprouts
Interventions
Eligibility Criteria
You may qualify if:
- BMI within the overweight range according to the World Health Organization criteria (24.9-29.9 kg/m2), aged 35-55 years, taking no vitamins, supplements or medication during the previous two months; no-smoking.
You may not qualify if:
- Diagnosed diseases as hypertension and cardiovascular pathologies, diabetes, hepatic, gastrointestinal and renal diseases, as well as the intake of drugs related to these pathologies, vegetarian diet, pregnancy or breastfeeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Baenas N, Villano D, Garcia-Viguera C, Moreno DA. Optimizing elicitation and seed priming to enrich broccoli and radish sprouts in glucosinolates. Food Chem. 2016 Aug 1;204:314-319. doi: 10.1016/j.foodchem.2016.02.144. Epub 2016 Feb 26.
PMID: 26988507BACKGROUNDBaenas N, Suarez-Martinez C, Garcia-Viguera C, Moreno DA. Bioavailability and new biomarkers of cruciferous sprouts consumption. Food Res Int. 2017 Oct;100(Pt 1):497-503. doi: 10.1016/j.foodres.2017.07.049. Epub 2017 Jul 21.
PMID: 28873713BACKGROUNDLopez-Chillon MT, Carazo-Diaz C, Prieto-Merino D, Zafrilla P, Moreno DA, Villano D. Effects of long-term consumption of broccoli sprouts on inflammatory markers in overweight subjects. Clin Nutr. 2019 Apr;38(2):745-752. doi: 10.1016/j.clnu.2018.03.006. Epub 2018 Mar 13.
PMID: 29573889DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Diego Ángel Moreno Fernández, PhD
National Research Council, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Proffesor
Study Record Dates
First Submitted
December 28, 2017
First Posted
January 4, 2018
Study Start
February 1, 2015
Primary Completion
July 1, 2016
Study Completion
July 1, 2017
Last Updated
January 4, 2018
Record last verified: 2017-12
Data Sharing
- IPD Sharing
- Will not share